Trial intelligence / Profile preview

Xamiol Gel vs Calcipotriol Scalp Solution in Scalp Psoriasis

NCT01195831Phase 3Completed

Sponsor
LEO Pharma
Start
Sep 2010
Primary completion
Mar 2011
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of calcipotriol + betamethasone in psoriasis, sponsored by LEO Pharma. Primary endpoint: Investigator's Global Assessment Success at 4 weeks. Started Sep 2010; status: completed.

02

Drugs

calcipotriol + betamethasone
03

Conditions

psoriasis

Beyond the preview

Go deeper on NCT01195831.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01195831.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call